Biosensor technology is an exciting area that involves many disciplines from physics to understand how the instruments work, to the knowledge of immunoassays, protein-protein interaction, DNA hybridization, viral and bacterial detection and more.
Biosensors are very important diagnostic tools today as they are one of the most valuable contributors that allow detection of clinically relevant molecules. The most common form of biosensor is the glucose biosensor where the usual format is a “sheet” and the reagent is dispensed to a pre-printed electrode pattern. In numerous applications of biosensors multiple layers of different samples are dispensed in different steps, entailing great flexibility as well as high positional accuracy. The sample is then allowed to dry down, cut and packaged.
Diabetes is a common disease without immediate cure. It has been rated as the third dangerous sicknesses after cardiopathy and cancer. Diabetes involves exact determination of the concentration of glucose in blood. Glucose biosensor offers a convenient and speedy technique for concentration determination of glucose in blood with poignant interest of many people. Imperatively diabetes treatment largely depends on glucose biosensors.
Biosensors could be used in Point-Of-Care Testing (POA) where the driving perception is to bring the test conveniently and immediately to the patient. This increases the possibility that the patient, physician, and care team will obtain the results quicker, further allowing immediate clinical management decisions. There is a lot of on going research aimed at developing highly reproducible, stable and selective interface chemistries for biosensors. Nowadays with the help of nanotechnology the designed sensors are much smaller, less power hungry and more sensitive than micro or macro sensors.
The potential market for biosensors is being driven by the boost in R&D activities. As they provide highly accurate real-time diagnosis the global demand for these equipments is ever growing. The emergence of intensive R&D activities and new technologies like microfluidics, and non-invasive biosensing alternatives form major market segments. According to the forecast of Medical Devices the worldwide demand for Biosensors can reach US $16.5 billion by the year 2017. Presently US ranks as the single largest market for Biosensors, followed closely by Europe.
Medical segment forms major portion of the market for biosensors. Specifically in the medical field biosensor uncover applications like blood glucose monitoring, drug discovery, drug analysis, complete blood analyzers for examining of blood gases, health linked signs including monitoring of cholesterol, glucose, and coagulation levels, electrolyte analyzers metabolite analyzers, vitamin analysis and water and wastewater analysis.
For more information about Non Contact Dispensing visit the site (http://www.biodot.com/)
Biosensors are very important diagnostic tools today as they are one of the most valuable contributors that allow detection of clinically relevant molecules. The most common form of biosensor is the glucose biosensor where the usual format is a “sheet” and the reagent is dispensed to a pre-printed electrode pattern. In numerous applications of biosensors multiple layers of different samples are dispensed in different steps, entailing great flexibility as well as high positional accuracy. The sample is then allowed to dry down, cut and packaged.
Diabetes is a common disease without immediate cure. It has been rated as the third dangerous sicknesses after cardiopathy and cancer. Diabetes involves exact determination of the concentration of glucose in blood. Glucose biosensor offers a convenient and speedy technique for concentration determination of glucose in blood with poignant interest of many people. Imperatively diabetes treatment largely depends on glucose biosensors.
Biosensors could be used in Point-Of-Care Testing (POA) where the driving perception is to bring the test conveniently and immediately to the patient. This increases the possibility that the patient, physician, and care team will obtain the results quicker, further allowing immediate clinical management decisions. There is a lot of on going research aimed at developing highly reproducible, stable and selective interface chemistries for biosensors. Nowadays with the help of nanotechnology the designed sensors are much smaller, less power hungry and more sensitive than micro or macro sensors.
The potential market for biosensors is being driven by the boost in R&D activities. As they provide highly accurate real-time diagnosis the global demand for these equipments is ever growing. The emergence of intensive R&D activities and new technologies like microfluidics, and non-invasive biosensing alternatives form major market segments. According to the forecast of Medical Devices the worldwide demand for Biosensors can reach US $16.5 billion by the year 2017. Presently US ranks as the single largest market for Biosensors, followed closely by Europe.
Medical segment forms major portion of the market for biosensors. Specifically in the medical field biosensor uncover applications like blood glucose monitoring, drug discovery, drug analysis, complete blood analyzers for examining of blood gases, health linked signs including monitoring of cholesterol, glucose, and coagulation levels, electrolyte analyzers metabolite analyzers, vitamin analysis and water and wastewater analysis.
For more information about Non Contact Dispensing visit the site (http://www.biodot.com/)